Which Stocks Are Set to Shine or Slip on November 7 2025?
About the Market Snapshot
The trading session of November 7 2025 opens amid mixed global cues. CNBC TV18’s Stocks to Watch list highlights firms that could see sharp price action as investors react to margin movements and Q2 updates. Positive earnings traction remains visible in healthcare and specialty manufacturing, while pressure lingers in engineering and consumer durable counters.
Strong quarterly EBITDA gains in SAI Life, Aster DM, and GSK Pharma reflect renewed domestic demand momentum, whereas ABB, Amber Enterprises, and Crompton drag sentiment owing to margin contraction.
Financial Highlights — Stocks to Watch (7 Nov 2025)
| Stock | EBITDA Change | Margin % | Comment |
|---|---|---|---|
| SAI Life | +42% | 27 vs 26 YoY | Operational efficiency boost |
| Kirloskar Ferrous | +11% | 12.3 vs 11.6 YoY | Volume driven growth |
| Indigo Paints | +11.7% | — | Net profit ↑ 10.8% YoY |
| Aster DM | +14% | — | Revenue ↑ 10% YoY |
| GSK Pharma | +4.5% | 34.4 vs 31.8 YoY | Margin expansion |
| ABB India | — | 15 vs 18.6 YoY | Order inflow ↓ 3% |
| Amber Enterprises | Missed Est. | Loss vs Profit | High input cost impact |
| JM Financial | EBITDA ↓ 29% | — | Revenue ↓ 7% QoQ |
| Amara Raja | −13.6% | 10.8 vs 13.3 | Soft auto battery cycle |
| Crompton | −22.6% | 8.2 vs 10.7 | Weak ECD margin |
Traders seeking derivative alignment can follow the Nifty F&O Tip for short-term setups on these momentum names.
Sector Performance Snapshot
| Sector | Trend | Key Driver |
|---|---|---|
| Healthcare | Positive | EBITDA expansion across hospitals |
| Capital Goods | Weak | Muted order flows (ABB) |
| Consumer Durables | Negative | Higher input costs hurt margins |
| Metals & Engineering | Stable | Volume recovery ongoing |
Defensive sectors continue to attract rotational buying as investors rebalance portfolios ahead of global macro data.
Strengths & Weaknesses
Strengths
|
Weaknesses
|
While short-term volatility persists, the underlying leadership remains concentrated in healthcare, metals, and selective auto ancillaries.
Opportunities & Threats
|
|
Valuation & Investment View
- Short-term: Focus on stocks with steady EBITDA visibility.
- Medium-term: Favor defensive themes with earnings resilience.
- Long-term: Accumulate leaders with consistent cash flows.
Index correlation strategists may track the BankNifty F&O Tip to align sectoral rotations with broader indices.
Investor Takeaway
Indian-Share-Tips.com Nifty Expert Gulshan Khera, CFP®, who is also a SEBI Registered Investment Adviser, notes that earnings-led rotation will define market momentum into mid-November. Explore more free sectoral insights at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
Related Queries on Stocks to Watch
- Which pharma stocks are showing margin expansion in FY26?
- How will order slowdown impact capital goods earnings?
- Is Crompton a value buy after the recent correction?
- Will GSK Pharma sustain its profitability momentum?
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
